284 related articles for article (PubMed ID: 23496653)
1. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
Carrillo-Muñoz AJ; Rojas F; Tur-Tur C; de Los Ángeles Sosa M; Diez GO; Espada CM; Payá MJ; Giusiano G
Mycoses; 2013 Sep; 56(5):571-5. PubMed ID: 23496653
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
4. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
[TBL] [Abstract][Full Text] [Related]
5. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility of Malassezia pachydermatis biofilm.
Figueredo LA; Cafarchia C; Otranto D
Med Mycol; 2013 Nov; 51(8):863-7. PubMed ID: 23834283
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology,
Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
[No Abstract] [Full Text] [Related]
9. Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
Pedrosa AF; Lisboa C; Faria-Ramos I; Silva R; Ricardo E; Teixeira-Santos R; Miranda I; Rodrigues AG
J Med Microbiol; 2019 May; 68(5):778-784. PubMed ID: 30907722
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest
Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY
Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
Gupta AK; Kohli Y; Li A; Faergemann J; Summerbell RC
Br J Dermatol; 2000 Apr; 142(4):758-65. PubMed ID: 10792228
[TBL] [Abstract][Full Text] [Related]
13. A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Rincón S; Cepero de García MC; Espinel-Ingroff A
J Clin Microbiol; 2006 Sep; 44(9):3429-31. PubMed ID: 16954293
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
Sancak B; Ayhan M; Karaduman A; Arikan S
Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing of Malassezia furfur against rilopirox.
Nenoff P; Haustein UF
Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole corneofungimetry bioassay on Malassezia species.
Piérard GE; Arrese JE; Piérard-Franchimont C
Mycoses; 2004 Oct; 47(9-10):418-21. PubMed ID: 15504126
[TBL] [Abstract][Full Text] [Related]
20. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
